Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma.
MetadataShow full item record
Genome-wide association studies (GWAS) have so far identified 25 loci associated with glioma risk, with most showing specificity for either glioblastoma (GBM) or non-GBM tumors. The majority of these GWAS susceptibility variants reside in noncoding regions and the causal genes underlying the associations are largely unknown. Here we performed a transcriptome-wide association study to search for novel risk loci and candidate causal genes at known GWAS loci using Genotype-Tissue Expression Project (GTEx) data to predict <i>cis</i>-predicted gene expression in relation to GBM and non-GBM risk in conjunction with GWAS summary statistics on 12,488 glioma cases (6,183 GBM and 5,820 non-GBM) and 18,169 controls. Imposing a Bonferroni-corrected significance level of <i>P</i> < 5.69 × 10<sup>-6</sup>, we identified 31 genes, including <i>GALNT6</i> at 12q13.33, as a candidate novel risk locus for GBM (mean <i>Z</i> = 4.43; <i>P</i> = 5.68 × 10<sup>-6</sup>). <i>GALNT6</i> resides at least 55 Mb away from any previously identified glioma risk variant, while all other 30 significantly associated genes were located within 1 Mb of known GWAS-identified loci and were not significant after conditioning on the known GWAS-identified variants. These data identify a novel locus (<i>GALNT6</i> at 12q13.33) and 30 genes at 12 known glioma risk loci associated with glioma risk, providing further insights into glioma tumorigenesis. SIGNIFICANCE: This study identifies new genes associated with glioma risk, increasing understanding of how these tumors develop.
Version of record
Genetic Predisposition to Disease
Gene Expression Regulation, Neoplastic
Polymorphism, Single Nucleotide
Quantitative Trait Loci
Genome-Wide Association Study
License start date
Cancer research, 2019, 79 (8), pp. 2065 - 2071